Law360, Wilmington (November 09, 2011, 8:03 PM ET) -- Medco Health Solutions Inc. agreed Monday to resolve shareholder class actions in Delaware and New Jersey federal court challenging the pharmacy benefit manager’s controversial $29 billion proposed merger with rival Express Scripts Inc.
In return for shareholders dropping the suits, the merger partners agreed to file additional disclosures on the deal in a proxy statement with the U.S. Securities and Exchange Commission, reduce a $950 million termination fee — payable to Express Scripts if the deal falls through — to $650 million, and reschedule a shareholder...
Medco, Investors Settle Over $29B Express Scripts Merger
To view the full article, take a free trial now.
